Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Risk Factors for Cervical Atherosclerosis in patients with Transient Ischemic Attack or Minor Ischemic Stroke
Stroke 24:970-975, Palomaki,H.,et al, 1993
One-Year Reduction and Longitudinal Analysis of Carotid Intima-Media Thickness Associated with Colestipol/Niacin Therapy
Stroke 24:1779-1783, Mack,W.J.,et al, 1993
Prediction of Carotid Stenosis Progression by Lipid & Hematologic Measurements
Neurol 39:1325-1331, Grotta,J.C.,et al, 1989
Relation Between Blood Lipids, Lipoproteins, and Cerebrovascular Atherosclerosis:A Review
Stroke 19:423-430, Tell,G.S.,et al, 1988
The Role of Plasma Lipids in Carotid Bifurcation Atherosclerosis
Ann Neurol 17:301-303, Ford,C.S.,et al, 1985
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Stroke 40:3526-3531,3413, Goldstein,L.,et al, 2009
Interventions in the Management of Serum Lipids for Preventing Stroke Recurrence
Stroke 40:e622-e623, Manktelow,B. &Potter,J., 2009
Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Stroke 39:2444-2448, Goldstein,L.B.,et al., 2008
Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973
Lioporotein and Apolipoprotein Profile in Men with Ischemic Stroke
Stroke 23:1556-1562, Pedro-Botet,J.,et al, 1992
Plasma Lipoproteins in Cortical Versus Lacunar Infarction
Stroke 20:448-452, Adams,R.J.,et al, 1989